ArticleCureus2026
Oral Manifestations of Juvenile Behçet Syndrome: A Case Report and Mini-Review of the Literature.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Behçet's disease is a chronic, relapsing, multisystem inflammatory vasculitis characterized by a broad spectrum of mucocutaneous and systemic manifestations. Oral ulcerations are often the earliest and most frequent clinical feature, playing a central role in diagnosis, particularly in pediatric patients, in whom the disease remains uncommon and its diagnosis is frequently delayed. We report the case of a boy aged 11 years and 6 months with juvenile Behçet syndrome who presented with recurrent oral aphthous ulcerations, including an 8-mm ulcer on the left lateral border of the tongue and a 5-mm ulcer on the external surface of the upper lip, along with poor oral hygiene and generalized gingival inflammation. The patient had a history of arthralgia and was receiving colchicine (1 mg/day). Oral management consisted of reinforcement of oral hygiene and dietary measures, full-mouth scaling, and topical treatment with corticosteroids and propolis-based therapy. At the 10-day follow-up, complete healing of the initial oral lesions and marked improvement in gingival inflammation were observed, although new aphthous ulcers developed at different intraoral sites, consistent with the relapsing nature of the disease. This case highlights the importance of early recognition of oral manifestations in Pediatric Behçet's Disease (PEDBD) and emphasizes the key role of pediatric dentists in facilitating diagnosis, multidisciplinary management, and long-term follow-up. Appropriate oral care may contribute to improved symptom control, enhanced quality of life, and the prevention of oral complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.